Multi-Center Study of Different Doses Domperidone in Feeding Intolerance

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions
Feeding IntolerancePremature BirthDomperidone OverdoseGastric Retention
Interventions
DRUG

Low dose

0.2mg group-The premature infant will be fed with 0.2mg/kg/tds domperidone and will be tested the residual glucose everyday in a 7-days period.

DRUG

normal dose

0.4mg group-The premature infant will be fed with 0.4mg/kg/tds domperidone and will be tested the residual glucose everyday in a 7-days period.

DRUG

over dose

0.6mg group-The premature infant will be fed with 0.6mg/kg/tds domperidone and will be tested the residual glucose everyday in a 7-days period.

DRUG

Glucose

Glucose group-The premature infant will be fed with glucose and will be tested the residual glucose everyday in a 7-days period.

Trial Locations (1)

510000

Nanfang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
collaborator

Guangdong Provincial Maternal and Child Health Hospital

OTHER

collaborator

Shen-Zhen City Maternity and Child Healthcare Hospital

OTHER

collaborator

Maternal and Child Health Hospital of Foshan

OTHER

collaborator

Guangzhou Panyu Central Hospital

OTHER

lead

Nanfang Hospital, Southern Medical University

OTHER

NCT02980250 - Multi-Center Study of Different Doses Domperidone in Feeding Intolerance | Biotech Hunter | Biotech Hunter